Vanguard Group’s Ocera Therapeutics, Inc. OCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $813K | Sell |
|
|||||
|
2017
Q2 | $871K | Sell |
|
|||||
|
2017
Q1 | $1.42M | Buy |
|
|||||
|
2016
Q4 | $365K | Sell |
|
|||||
|
2016
Q3 | $1.14M | Buy |
|
|||||
|
2016
Q2 | $777K | Buy |
|
|||||
|
2016
Q1 | $1.19M | Buy |
|
|||||
|
2015
Q4 | $1.19M | Buy |
|
|||||
|
2015
Q3 | $1.16M | Buy |
|
|||||
|
2015
Q2 | $1.36M | Buy |
|
|||||
|
2015
Q1 | $1.62M | Buy |
|
|||||
|
2014
Q4 | $1.84M | Sell |
|
|||||
|
2014
Q3 | $1.44M | Buy |
|
|||||
|
2014
Q2 | $1.58M | Buy |
|
|||||
|
2014
Q1 | $2.18M | Buy |
|
|||||
|
2013
Q4 | $2.04M | Buy |
|
|||||
|
2013
Q3 | $951K | Buy |
|
|||||
|
2013
Q2 | $47K | Buy |
|